Home › Metastatic Cancer › California › Glendale
Metastatic Cancer clinical trials in Glendale, CA
3 studies for Metastatic Cancer are looking for participants at sites in and around Glendale (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
RecruitingPhase 3
- Research Site, Glendale
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
RecruitingPhase 3
- Oncura Health - Corporate (Central IDS & Regulatory Only), Glendale
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
RecruitingPhase 3
- Los Angeles Cancer Network_Glendale, Glendale
Metastatic Cancer trials in other cities
- Houston, TX104 studies
- New York City, NY93 studies
- Nashville, TN70 studies
- Boston, MA63 studies
- Los Angeles, CA57 studies
- St. Louis, MO54 studies
- Arlington, VA53 studies
- Philadelphia, PA46 studies
- Chicago, IL45 studies
- San Antonio, TX44 studies
- Washington, DC43 studies
- Dallas, TX42 studies
Other studies in Glendale
- Major Depressive Disorder12 studies
- Non-Small Cell Lung Cancer9 studies
- Depression6 studies
- Cancer (all types)5 studies
- Obesity5 studies
- Breast Cancer4 studies
- Colorectal Cancer4 studies
- Lung Cancer4 studies
- Coronary Artery Disease3 studies
- Melanoma3 studies
- Macular Edema3 studies
- Overweight3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.